Avalere Participates in Initiative to Advance the Identification and Management of Heart Valve Disease

  • This page as PDF


In January 2018, Avalere Health partnered with the Society of Cardiovascular and Angiography Interventions to launch the development of the Heart Valve Initiative.
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.

The goal of the Initiative is to advance the identification and management of patients with heart valve disease. To define the priority gap areas in the identification and management of valve disease, Avalere and SCAI researchers conducted a formal environmental scan to uncover current and planned initiatives that might inform the development of the initiative and bring to light stakeholder activities that seek to address the target patient population. This document summarizes the methodology and key findings from the scan, which is informing the development of interventions, research questions, and quality measure concepts that will be tested in a pilot in August 2019.

Read the findings.

To receive Avalere updates, connect with us.

Webinar | Election 2024: What’s at Stake for Healthcare? 

On August 14 at 1:30 PM ET, Avalere experts and guests will discuss the 2024 elections, exploring the candidates’ health policy approaches and implications for stakeholders. 

Learn More

From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about Value-Based Care
Please enter your email address to be notified when new Value-Based Care insights are published.

Back To Top